Huijuan Li, Xueyan Liang, Shiran Qin, Xiaoyu Chen, Liju Huang, Yan Li. "First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis." PLoS ONE (2025). https://doi.org/10.1371/journal.pone.0324057